Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $2.09 Million - $2.99 Million
35,163 New
35,163 $2.8 Million
Q2 2023

Aug 08, 2023

BUY
$45.44 - $71.21 $77,066 - $120,772
1,696 Added 28.89%
7,567 $538,000
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $105,180 - $125,794
2,397 Added 69.0%
5,871 $294,000
Q4 2022

Feb 13, 2023

SELL
$40.82 - $57.75 $114,459 - $161,931
-2,804 Reduced 44.66%
3,474 $151,000
Q3 2022

Nov 07, 2022

BUY
$46.84 - $58.49 $294,061 - $367,200
6,278 New
6,278 $334,000
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $617,073 - $804,854
-13,920 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$40.27 - $56.99 $386,712 - $547,274
-9,603 Reduced 40.82%
13,920 $618,000
Q3 2021

Nov 09, 2021

BUY
$47.43 - $84.23 $1.12 Million - $1.98 Million
23,523 New
23,523 $1.13 Million
Q2 2021

Aug 12, 2021

SELL
$73.06 - $97.7 $413,884 - $553,470
-5,665 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$70.43 - $97.42 $314,117 - $434,493
4,460 Added 370.12%
5,665 $475,000
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $58,924 - $90,688
1,205 New
1,205 $90,000
Q3 2020

Nov 16, 2020

SELL
$37.23 - $50.97 $303,498 - $415,507
-8,152 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$28.78 - $46.83 $123,322 - $200,666
4,285 Added 110.81%
8,152 $313,000
Q1 2020

May 13, 2020

SELL
$25.53 - $70.14 $275,009 - $755,548
-10,772 Reduced 73.58%
3,867 $119,000
Q4 2019

Feb 10, 2020

BUY
$54.18 - $65.64 $793,141 - $960,903
14,639 New
14,639 $797,000
Q3 2019

Nov 12, 2019

SELL
$58.58 - $83.91 $937,280 - $1.34 Million
-16,000 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$63.59 - $78.71 $680,858 - $842,747
10,707 Added 202.29%
16,000 $1.21 Million
Q1 2019

May 13, 2019

BUY
$50.75 - $80.54 $268,619 - $426,298
5,293 New
5,293 $414,000
Q1 2018

May 11, 2018

SELL
$26.05 - $34.5 $394,136 - $521,985
-15,130 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$24.5 - $36.01 $183,186 - $269,246
7,477 Added 97.7%
15,130 $388,000
Q3 2017

Nov 07, 2017

BUY
$31.26 - $42.03 $239,232 - $321,655
7,653
7,653 $252,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.